Paper Information

Title: 

COMPLIANCE ASSESSMENT IN HEMODYALYSIS PATIENTS WITH DRUG REGIMEN, POTASSIUM AND FLUID RESTRICTION AND ITS RELATIONSHIP WITH DEMOGRAPHIC FACTORS

Type: POSTER
Author(s): MINAEIAN M.,SHAHIDI SHAHRZAD,MIRMOGHTADAEI P.,SHOKRI S.*
 
 *ISFAHAN UNIVERSITY OF MEDICAL SCIENCES, SCHOOL OF PHARMACY AND ISFAHAN PHARMACEUTICAL RESEARCH CENTER
 
Name of Seminar: IRANIAN CONGRESS OF PHYSIOLOGY AND PHARMACOLOGY
Type of Seminar:  CONGRESS
Sponsor:  PHYSIOLOGY AND PHARMACOLOGY SOCIETY, MASHHAD UNIVERSITY OF MEDICAL SCIENCE
Date:  2009Volume 19
 
 
Abstract: 

Background: Compliance is important in hemodialysis patients because of the chronic nature of the renal diseases and their complex drug regimen. The present study was carried out to assess the compliance status in such patients and to determine the demographic factors may cause or contribute in non-compliance.
Materials and Methods: This cross sectional study was carried out on 185 patients (age average=51.9Y) of 3 dialysis center of Isfahan during the year of 1387. The compliance with antihypertensive drugs, phosphorus binders, potassium and fluid restriction was evaluated using Morrisky questionnaire and measurement of blood pressure, serum level of Phosphorus and potassium, and weight gain before start of treatment and during dialysis periods (3 times) respectively. Demographic data was collected from medical records.
Results: Non-compliance was 50.7% with anti-hypertensive drugs, 66.5% with phosphorus binders, 27.6% with potassium intake limits and 89.8% with fluid restriction. Drug regimen complexity and unpleasant adverse drug reactions were two important factors for non-compliance with anti-hypertensive and phosphorus binders. Young age was the only demographic factor contributing in non-compliance with potassium and fluid restrictions.
Discussion: Our findings suggest that it is necessary to improve the compliance status in hemodialysis patients especially in younger ones. Better compliance with potassium restriction may be due to more patients’ knowledge about hyperkalemia induced dangerous effects and/or efficacious therapeutic interventions.

 
Keyword(s): COMPLIANCE, HEMODIALYSIS PATIENTS, ANTI-HYPERTENSIVE DRUGS, PHOSPHORUS, POTASSSUIM, FLUID RESTRICTION
 
Yearly Visit 19   tarjomyar
 
Latest on Blog
Enter SID Blog